| Title |
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, March 2023
|
| DOI | 10.2147/ndt.s391096 |
| Pubmed ID | |
| Authors |
Xu Chen, Xuan Hou, Daisy Bai, Rosanne Lane, Chong Zhang, Carla Canuso, Gang Wang, Dong-Jing Fu |
X Demographics
The data shown below were collected from the profiles of 77 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 18% |
| United Kingdom | 7 | 9% |
| Poland | 2 | 3% |
| Germany | 2 | 3% |
| Turkey | 1 | 1% |
| Denmark | 1 | 1% |
| Canada | 1 | 1% |
| Netherlands | 1 | 1% |
| Spain | 1 | 1% |
| Other | 4 | 5% |
| Unknown | 43 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 40 | 52% |
| Scientists | 22 | 29% |
| Practitioners (doctors, other healthcare professionals) | 12 | 16% |
| Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 16 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 2 | 13% |
| Other | 1 | 6% |
| Student > Doctoral Student | 1 | 6% |
| Unspecified | 1 | 6% |
| Professor | 1 | 6% |
| Other | 3 | 19% |
| Unknown | 7 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 5 | 31% |
| Psychology | 2 | 13% |
| Unspecified | 1 | 6% |
| Unknown | 8 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2024.
All research outputs
#987,632
of 25,895,862 outputs
Outputs from Neuropsychiatric Disease and Treatment
#127
of 3,153 outputs
Outputs of similar age
#21,123
of 426,864 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 45 outputs
Altmetric has tracked 25,895,862 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.